• we cover more than 1,000 news per day, in 2 languages, and 83,000 stocks
Light Dark
it
italian it
english en

Berberine: One Of The Most Powerful Tools We Have To Regulate Insulin

www.zerohedge.com 22-12-2024 08:10 5 Minutes reading
Berberine: One Of The Most Powerful Tools We Have To Regulate Insulin Authored by Robert W Malone via The Epoch Times (emphasis ours),While at the Brownstone Institute retreat near Hartford, Connecticut last year, I heard Dr. Paul Marik speak on repurposed drugs. Of course, this has been one of my passions since the Ebola outbreak of 2014, with the realization that a safe and effective vaccine could not be developed fast enough for any newly emergent highly infectious disease or infectious bio-threat event.As Berberine is derived from plants, it is considered a nutraceutical. svf74/ShutterstockUnfortunately, there is no interest in using repurposed drugs by our government or pharma for other disease indications such as cancer. This is despite the fact that computerized modeling, which is very sophisticated, suggests that there are many drugs for which the already licensed drug’s safety profile is well known, that would work well for varying types of cancers. Again, no profit motive, no interest. No research dollars or support. A dead end.Likewise, in the United States, “nutraceuticals” are largely unregulated, as they exist in the same category as dietary supplements and food additives by the FDA [U.S. Food and Drug Administration]. There is no way for a pharma company to make huge amounts of profits from repurposed drugs unless they can figure out a way to patent the product (formulations, co-administration with other agents, etc.). Even then, it can be very difficult and carries a lot of financial risk—in getting it through the patenting process (which is more difficult).One of the key examples used during Marik’s lecture at the Brownstone retreat was the compound berberine.As berberine is derived from plants, it is considered a nutraceutical. As a consequence, there are few randomized clinical trials and little pharma or government interest in the drug. Probably because there is no profit motive at play here. Hence, most of us have never heard of it.One of Marik’s main points was that berberine appears to be one of the most powerful tools we have to regulate insulin and yet because there is no profit in promoting this product, there is almost no publicity or significant research into its clinical benefits.Traditional medicines use many plants that are true miracles provided to us by nature. Berberine is found in many plants throughout the world and has been used as an essential medicine globally for more than 3000 years. Traditionally, its uses have varied greatly and include treating infections and sores, and as an antimicrobial for various kinds of gastrointestinal inflammation.Enzymes are proteins that function as biological catalysts in the body and act by accelerating chemical reactions. Berberine works by binding to a variety of individual enzymes and altering their efficiency.What are the Health Benefits of Berberine?(Note—there is no question that more research into this compound is needed. But there is overwhelming evidence that this drug has many health benefits and should not be overlooked when assessing the use of dietary nutraceutical supplements.)Atherosclerosis“Atherosclerosis is a chronic inflammatory disease of the arteries, and is the underlying cause of about 50% of all deaths in westernized society”“Berberine is an extract of Chinese traditional herbs that is known for its antimicrobial and anti-inflammatory effects in the digestive system. Its underlying anti-CVD (cardiovascular disease) mechanisms are currently attracting interest, and its pharmacological actions, such as antioxidation, regulation of neurotransmitters and enzymes, and cholesterol-lowering effects, have been substantiated. Recent studying found that berberine could inhibit both the proliferation and apoptosis of VSMCs (vascular smooth muscle cells) induced by mechanical stretch stress simultaneously, which suggests that berberine might be an excellent drug to treat atherosclerosis.” Frontiers in Pharmacology, 2021Blood PressureBerberine has been shown to help control blood pressure.Blood Sugar Control (Insulin Regulation)Berberine has been shown to significantly lower glucose levels in diabetic patients.One study shows that berberine plus probiotics had the greatest effect on blood sugar levels, although berberine alone also was clinically significant in reducing blood glucose levels, whereas placebo and probiotics-alone control treatments were ineffective in these studies. It was noted that berberine induced more gastrointestinal side effects relative to the control groups.Cholesterol“Men randomized to berberine had larger reductions in total cholesterol (-0.39 mmol/L, 95% confidence interval (CI) -0.70 to -0.08) and high-density lipoprotein cholesterol (-0.07 mmol/L, 95% CI -0.13 to -0.01) after 12 weeks. Considering changes after 8 and 12 weeks together, berberine lowered total cholesterol and possibly low-density lipoprotein-cholesterol (LDL-c), and possibly increased testosterone.” Nutrients, 2021.Taking berberine supplements regularly appears to lower total cholesterol, “bad” cholesterol, and triglycerides in people with high cholesterol. As it is not a statin and works through other pathways than statin drugs, it may be beneficial for people who wish to lower cholesterol but do not wish to take statins or are resistant to statins.(The issue of statins is complex and not as clear-cut as many think. But this essay is not the place for that discussion. I promise though—at some point in time, we will get to that analysis).Heart DiseasePeople with heart disease often have fatigue and irregular heartbeats. Studies show that taking berberine supplement combined with standard heart disease treatments reduces these symptoms. Berberine reduced the risk of death from heart disease without apparent side effects.“One hundred fifty-six patients with CHF and >90 ventricular premature complexes (VPCs) and/or nonsustained ventricular tachycardia (VT) on 24-hour Holter monitoring were randomly divided into 2 groups. All patients were given conventional therapy for CHF, consisting of angiotensin-converting enzyme inhibitors, digoxin, diuretics, and nitrates. Patients in the treatment group (n = 79) were also given berberine 1.2 to 2.0 g/day. The remaining 77 patients were given placebo.” ...“After treatment with berberine, there was a significantly greater increase in LVEF, exercise capacity, improvement of the dyspnea-fatigue index, and a decrease of frequency and complexity of VPCs compared with the control group. There was a significant decrease in mortality in the berberine-treated patients during long-term follow-up ... p AM J Cardiology, 2003 Note—this study was conducted in 2003, and yet only crickets have been heard from the American Heart Association concerning the benefits of berberine.Check out Dr. Malone here...And snag some Berberine here... Tyler DurdenSun, 12/22/2024 - 15:10

Info

Related news
The Musk-Led Manufacturing Revolution Nobody Is Ta...
25.12.24 04:15
by zerohedge.com

The Musk-Led Manufacturing Revolution Nobody Is Talking About

The Musk-Led Manufacturing Revolution Nobody Is Talking About When most analysts discuss Tesla, they focus on new vehicles or the electric vehicle company’s advancements in autonomy. Yet, according to Launch i/o CEO Jeff Lutz, one of the most significant—and under-discussed—developments at Tesla is happening not in its design studios or on the road, but in its factories. Lutz, a former executive at Google and Motorola, argues that Tesla’s true innovation isn’t just the electric vehicles or robots it’s building, but how those products are being made. The company’s first-principles approach to manufacturing is a radical departure from the industry norm, focusing not just on cheap labor or existing models, but on rethinking the entire production process.Tesla is creating factories that are the product—designing, testing, and perfecting every element just as they do with their cars. This focus on manufacturing efficiency, Lutz believes, will lead to a dramatic reduction in production costs, potentially bringing them closer to zero. And this shift in how products are built—rather than merely assembled—could set a new standard for the entire manufacturing world..@thejefflutz to @farzyness: Tesla is Revolutionizing Manufacturing—And Few Are Talking About It"The most under-discussed thing in the analyst world about Tesla is not the new vehicles coming, nor the growing discussions about autonomy, but rather Tesla's next product: their... pic.twitter.com/a5a60vBxJR— CAPITAL (@capitalnewshq) December 25, 2024FARZAD MESBAHI: It's no wonder that innovation has been lacking so much it's because we've brute forced essentially manufacturing by leveraging globalization because we had that $2 an hour rate in China or Mexico wherever else like we're not like well we have to just get really good at building stuff to be competitive I was like nah just let him do it like we'll get get our margins just let them do it.JEFF LUTZ: The most under-discussed thing in the analyst world about Tesla is not the new vehicles coming, nor the growing discussions about autonomy, but rather Tesla's next product: their new way of manufacturing. It's a big deal, a huge step in how products are made today, and I don't think many investment firms have the right research people actually looking into what this impact is and what it's going to enable. It's going to enable the variable cost to build products to shrink further and further, approaching zero.This is the step function needed for cost reduction to achieve further scale, and I don’t think enough people are talking about it. It’s going to be how the Cybertruck is made, how Optimus will be made. Tesla versions its factories like they version their product. They spend time perfecting it and have design reviews of their factory designs just as they do with their products. They have specs and performance attributes they are trying to meet. This is very different from what happens at other companies at the executive level.FARZAD MESBAHI: This is such a profound statement beca...

Sentiment
-0.43
Bearish/Bullish
50